ArticleJournal of ovarian research2026
Single-cell dissection of regulated cell death dynamics in ovarian aging.
Article in Journal of ovarian research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Possibility and Characteristics of Senescence-Related Changes in Reproductive Tissues Such as the Ovary, Oviduct, and Uterus.Reproductive medicine and biologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundOvarian aging drives declining fertility, premature menopause, and systemic age-related diseases. Multiple different types of regulated cell death (RCD) pathways have been identified and play integral roles in diverse physiological and pathological processes. However, the RCD landscape of ovarian aging remains uncharacterized at single-cell resolution.
resultsHere, we conducted single-cell RNA sequencing (scRNA-seq) on murine ovaries across aging (3, 9, 12 and 15 months), and mapped pan-RCD dynamics, including apoptosis, ferroptosis, parthanatos, and ten other pathways, revealing cell-type-specific RCD trajectories. These pathways exhibited distinct changes with ovarian aging, highlighting cell heterogeneity. Notably, apoptosis and parthanatos pathways demonstrated high correlations and rates of change with advancing age. Parthanatos was particularly notable for exhibiting one of the steepest age-associated increases. Cross-species validation using human ovarian scRNA-seq and GTEx V8 transcriptomics confirmed conserved parthanatos upregulation with age, negatively correlating with the expression levels of key enzymes in hormone synthesis.
conclusionsThe study deciphers the RCD patterns in murine and human ovarian aging, nominating parthanatos as a targetable node for combating ovarian aging and enhancing female fertility.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.